Innovative ETFs ChannelBiotech ETFs Pop After Novartis Acquires Medicines Co.By Max ChenNovember 25, 2019
WebcastsAn Active ETF Approach to Target Innovations in Next Generation SequencingBy Max ChenNovember 14, 2019
Innovative ETFs ChannelBiotech ETFs Strengthen as Amgen Invests in China’s BeiGeneBy Max ChenNovember 1, 2019
Innovative ETFs ChannelDrug Pricing Reforms Keep Pressure on Biotech, Healthcare ETFsBy Max ChenSeptember 26, 2019
Innovative ETFs ChannelBiotech ETFs Strengthen After Judge Blocks Trump’s Drug Pricing RuleBy Max ChenJuly 9, 2019
Innovative ETFs ChannelAbbVie, Allergan Deal Puts Spotlight on Pharmaceutical ETFsBy Max ChenJune 25, 2019
Innovative ETFs ChannelBiotech ETFs Are Breaking Out on Pfizer’s Array Biopharma DealBy Max ChenJune 17, 2019
Innovative ETFs ChannelHealthcare, Biotech ETFs Plunge on Mounting Political PressuresBy Max ChenApril 18, 2019
Equity ETF ChannelA Targeted ETF to Capture M&A, Consolidation in the Biotech SpaceBy Max ChenApril 10, 2019
